within Pharmacolibrary.Drugs.N_NervousSystem.N02C_AntimigrainePreparations.N02CA01_Dihydroergotamine;

model Dihydroergotamine_2
  extends Pharmacolibrary.Drugs.ATC.N.N02CA01_2;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>N02CA01_2</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Dihydroergotamine is an ergot alkaloid medication primarily used for the treatment of migraine headaches and cluster headaches. It acts as a vasoconstrictor of intracranial arteries, and as an agonist at serotonin (5-HT1) receptors. It is approved and still in use for acute migraine attacks by several regulatory agencies.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for oral administration in adults, since bioavailability is extremely low and no direct population PK model reported.</p><h4>References</h4><ol><li><p>Lipton, RB, et al., &amp; Albrecht, D (2025). Relationship of dihydroergotamine pharmacokinetics, clinical efficacy, and nausea-A narrative review. <i>Headache</i> 65(3) 527–535. DOI:<a href=&quot;https://doi.org/10.1111/head.14877&quot;>10.1111/head.14877</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/39601088/&quot;>https://pubmed.ncbi.nlm.nih.gov/39601088</a></p></li><li><p>Humbert, H, et al., &amp; Lavène, D (1996). Human pharmacokinetics of dihydroergotamine administered by nasal spray. <i>Clinical pharmacology and therapeutics</i> 60(3) 265–275. DOI:<a href=&quot;https://doi.org/10.1016/S0009-9236(96)90053-3&quot;>10.1016/S0009-9236(96)90053-3</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8841149/&quot;>https://pubmed.ncbi.nlm.nih.gov/8841149</a></p></li><li><p>de Marées, H, et al., &amp; Knaup, G (1986). Relationship between the venoconstrictor activity of dihydroergotamine and its pharmacokinetics during acute and chronic oral dosing. <i>European journal of clinical pharmacology</i> 30(6) 685–689. DOI:<a href=&quot;https://doi.org/10.1007/BF00608216&quot;>10.1007/BF00608216</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3533566/&quot;>https://pubmed.ncbi.nlm.nih.gov/3533566</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Dihydroergotamine_2;
